Prophylaxis Roles of IL-2 Treatment on GVHD After Transplantation
NCT02659657
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
70
Enrollment
OTHER
Sponsor class
Conditions
Acute Graft-versus-host Disease
Interventions
DRUG:
Interleukin-2
Sponsor
Peking University People's Hospital